[Trisomy 18 syndrome: A case report].
Saldarriaga W, Rengifo-Miranda H, Ramírez-Cheyne J.
Rev Chil Pediatr. 2016 Mar-Apr;87(2):129-36. doi: 10.1016/j.rchipe.2015.08.006. Epub 2015 Oct 12.
Surveillance guidelines for children with trisomy 18.
Kepple JW, Fishler KP, Peeples ES.
Am J Med Genet A. 2021 Apr;185(4):1294-1303. doi: 10.1002/ajmg.a.62097. Epub 2021 Feb 2.
[Trisomy 18 or postnatal Edward´s syndrome: descriptive study conducted at the University Hospital Center of Casablanca and literature review].
Outtaleb FZ, Errahli R, Imelloul N, Jabrane G, Serbati N, Dehbi H.
Pan Afr Med J. 2020 Dec 3;37:309. doi: 10.11604/pamj.2020.37.309.26205. eCollection 2020.
Trisomy 18: review of the clinical, etiologic, prognostic, and ethical aspects.
Rosa RF, Rosa RC, Zen PR, Graziadio C, Paskulin GA.
Rev Paul Pediatr. 2013 Jan-Mar;31(1):111-20. doi: 10.1590/s0103-05822013000100018.
A tumor profile in Edwards syndrome (trisomy 18).
Satgé D, Nishi M, Sirvent N, Vekemans M.
Am J Med Genet C Semin Med Genet. 2016 Sep;172(3):296-306. doi: 10.1002/ajmg.c.31511. Epub 2016 Jul 30.
Trisomy 13 and 18-Prevalence and mortality-A multi-registry population based analysis.
Goel N, Morris JK, Tucker D, de Walle HEK, Bakker MK, Kancherla V, Marengo L, Canfield MA, Kallen K, Lelong N, Camelo JL, Stallings EB, Jones AM, Nance A, Huynh MP, Martínez-Fernández ML, Sipek A, Pierini A, Nembhard WN, Goetz D, Rissmann A, Groisman B, Luna-Muñoz L, Szabova E, Lapchenko S, Zarante I, Hurtado-Villa P, Martinez LE, Tagliabue G, Landau D, Gatt M, Dastgiri S, Morgan M.
Am J Med Genet A. 2019 Dec;179(12):2382-2392. doi: 10.1002/ajmg.a.61365. Epub 2019 Sep 30.
Holoprosencephaly.
Society for Maternal-Fetal Medicine (SMFM); Monteagudo A.
Am J Obstet Gynecol. 2020 Dec;223(6):B13-B16. doi: 10.1016/j.ajog.2020.08.178. Epub 2020 Nov 7.
Anatomy of trisomy 18.
Roberts W, Zurada A, Zurada-ZieliŃSka A, Gielecki J, Loukas M.
Clin Anat. 2016 Jul;29(5):628-32. doi: 10.1002/ca.22725. Epub 2016 May 3.
Non-invasive prenatal testing.
Harraway J.
Aust Fam Physician. 2017 Oct;46(10):735-739.
TRIDENT-2: National Implementation of Genome-wide Non-invasive Prenatal Testing as a First-Tier Screening Test in the Netherlands.
van der Meij KRM, Sistermans EA, Macville MVE, Stevens SJC, Bax CJ, Bekker MN, Bilardo CM, Boon EMJ, Boter M, Diderich KEM, de Die-Smulders CEM, Duin LK, Faas BHW, Feenstra I, Haak MC, Hoffer MJV, den Hollander NS, Hollink IHIM, Jehee FS, Knapen MFCM, Kooper AJA, van Langen IM, Lichtenbelt KD, Linskens IH, van Maarle MC, Oepkes D, Pieters MJ, Schuring-Blom GH, Sikkel E, Sikkema-Raddatz B, Smeets DFCM, Srebniak MI, Suijkerbuijk RF, Tan-Sindhunata GM, van der Ven AJEM, van Zelderen-Bhola SL, Henneman L, Galjaard RH, Van Opstal D, Weiss MM; Dutch NIPT Consortium.
Am J Hum Genet. 2019 Dec 5;105(6):1091-1101. doi: 10.1016/j.ajhg.2019.10.005. Epub 2019 Nov 7.
